Literature DB >> 18222538

Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.

A Rajakumar1, H M Michael, A Daftary, A Jeyabalan, C Gilmour, K P Conrad.   

Abstract

Hypoxia-inducible transcription factor-1alpha and -2alpha (HIF-alpha) proteins and regulated genes are increased in preeclamptic (PE) placentas. Although placental hypoxia likely stabilizes HIF-alpha proteins, we previously reported that there is also a defect in oxygen-dependent reduction of HIF-alpha proteins in PE relative to normal pregnant (NP) placentas that could contribute to their over-expression. After a 4-h exposure to 2% oxygen, placental villous explants were exposed to 21% oxygen over 90 min. As assessed by Western analysis, the defective oxygen-dependent reduction of HIF-1alpha protein in villous explants from PE placenta was unaffected by the protein synthesis inhibitor, cycloheximide. However, after incubation with the proteasomal inhibitor, clasto-lactacystin, oxygen-dependent reduction of HIF-1alpha protein was markedly and similarly impaired in the villous explants from both normal and PE placentas. Thus, impairment of protein degradation rather than increased synthesis causes inadequate oxygen-dependent reduction of HIF-1alpha protein in PE placentas. Immunoprecipitation studies revealed comparable association of HIF-1alpha with von Hippel Lindau (VHL) protein in placentas from NP and PE women. Furthermore, prolyl hydroxylase-3 protein was appropriately upregulated in the PE placentas as determined by Western analysis paralleling the increases of HIF-alpha proteins. These results suggest that molecular events leading to the formation of the HIF-1alpha:VHL:ubiquitin ligase complex are most likely not impaired in PE placentas. Finally, proteasomal trypsin, chymotrypsin, and peptidyl glutamyl-like activities were significantly reduced by approximately 1/3 in PE placentas by using specific peptide substrates coupled to a fluorescent tag. Unexpectedly, however, they were even further decreased in placentas from normotensive women delivering growth restricted babies >37 weeks gestation-placentas which do not have elevated HIF-alpha proteins. In conclusion, accumulation of HIF-alpha proteins in PE placentas may occur as a consequence of both increased formation secondary to relative ischemia/hypoxia and reduced degradation after reperfusion/oxygenation consequent to proteasomal dysfunction. In contrast, in placentas from normotensive women delivering growth restricted babies >37 weeks gestation, proteasomal activity, albeit markedly reduced, is adequate to cope with degradation of HIF-alpha proteins, which have not been increased by an hypoxic environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222538     DOI: 10.1016/j.placenta.2007.11.015

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  19 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

2.  Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells.

Authors:  Ping Lin; Jiejun Fu; Binjiahui Zhao; Feng Lin; Haifeng Zou; Leiyu Liu; Cheng Zhu; Hongmei Wang; Xiaoguang Yu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

Review 3.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

4.  Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia.

Authors:  Travers Ching; Min-Ae Song; Maarit Tiirikainen; Janos Molnar; Marla Berry; Dena Towner; Lana X Garmire
Journal:  Mol Hum Reprod       Date:  2014-06-18       Impact factor: 4.025

5.  Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.

Authors:  Katrin Wenzel; Augustine Rajakumar; Hannelore Haase; Nele Geusens; Norbert Hubner; Herbert Schulz; Justin Brewer; Lyndsay Roberts; Carl A Hubel; Florian Herse; Lydia Hering; Fatimunnisa Qadri; Carsten Lindschau; Gerd Wallukat; Robert Pijnenborg; Harald Heidecke; Gabriela Riemekasten; Friedrich C Luft; Dominik N Muller; Babette Lamarca; Ralf Dechend
Journal:  Hypertension       Date:  2011-05-16       Impact factor: 10.190

Review 6.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

7.  AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.

Authors:  Ambart E Covarrubias; Edouard Lecarpentier; Agnes Lo; Saira Salahuddin; Kathryn J Gray; S Ananth Karumanchi; Zsuzsanna K Zsengellér
Journal:  Am J Pathol       Date:  2018-10-11       Impact factor: 4.307

Review 8.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

Review 9.  Hypoxia and Placental Development.

Authors:  Michael J Soares; Khursheed Iqbal; Keisuke Kozai
Journal:  Birth Defects Res       Date:  2017-10-16       Impact factor: 2.344

Review 10.  Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

Authors:  K G Pringle; K L Kind; A N Sferruzzi-Perri; J G Thompson; C T Roberts
Journal:  Hum Reprod Update       Date:  2009-11-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.